No article text was recorded for this version.
glycan shielding
Version 1 of 122 papers36 conceptsfrozen 2026-10-04
Papers in this version
- Blog: The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
- Blog: Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
- Blog: Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains
- Blog: Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold
- Blog: Structural Evolution of Trimeric Gamma-Type Retroviral Envelope Proteins
- Blog: Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops
- Blog: Population analysis of Legionella pneumophila reveals a basis for resistance to complement-mediated killing
- Blog: Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses
- Blog: Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy
- Blog: Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-like antibodies
- Blog: Deep time structural evolution of retroviral and filoviral surface envelope proteins
- Blog: Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming
- Blog: Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes
- Blog: Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
- Blog: Three dimensional structure directs T-cell epitope dominance associated with allergy
- Blog: Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
- Blog: An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
- Blog: Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H<sub>3</sub>N<sub>2</sub>
- Blog: A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) viruses
- Blog: The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates
- Blog: Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
- Blog: Germinal centers are permissive to subdominant antibody responses
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_glycan_shielding_2d0b5225,
title = {glycan shielding},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/glycan-shielding/rdr_2d0b52252a8c45e59718f11b8649f8c9},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_glycan_shielding_2d0b5225_v1,
title = {glycan shielding},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/glycan-shielding/rdr_2d0b52252a8c45e59718f11b8649f8c9/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}